Massivemarkets

BCDA

BioCardia, Inc. Common Stock

Nasdaq · usd

$0.8906-0.03 (-3.30%)
As of 2:19:59 PM EDT on Oct 26, 2026 · 15-minute delayed

BioCardia, Inc. Common Stock (BCDA) trades at $0.8906 (-3.30%) as of 2:19:59 PM EDT on Oct 26, 2026, -15.18% over the past month. Market cap is $13.94M, with 1.3 days to cover in short interest.

Stock performance

How BioCardia, Inc. Common Stock (BCDA) stock has performed from one day to one year, with its 52-week range.

-2.13%
-$0.02 over 1D
$0.87$0.88$0.90$0.929:30 AM10:40 AM11:55 AM1:05 PM2:15 PM$0.89
1D
-3.30%
1W
-0.77%
1M
-15.18%
YTD
-28.75%
1Y
-32.02%
52-wk range
$0.75 – $1.80

Key statistics

Today's trading snapshot for BCDA: day range, open, previous close, volume and market cap.

Day range
$0.86 – $0.93
Open
$0.93
Prev close
$0.92
Volume
113.95K
Market cap
$13.94M
Shares out
15.14M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for BioCardia, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
—
P/B
5.16
P/FCF
—
ROE
-271.8%
ROA
-154.3%
Debt/Equity
0.00
Div yield
0.00%

As of Oct 23, 2026

8-K filings

Material corporate events BioCardia, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Investor presentationOct 7, 2026

    On October 7, 2026, BioCardia, Inc. issued a press release reporting that BioCardia presents CardiAMP HF II Trial design at Heart Failure Society of America Annual Scientific Meeting.

  • Listing compliance regainedSep 21, 2026

    On September 21, 2026, the Staff notified the Company in writing that the Staff had determined that the closing bid price of the Company's common stock had been at $1.00 per share or greater for at least 10 consecutive business days and, accordingly, that the Company had regained compliance with the Minimum Bid Price Requirement for continued listing on the Nasdaq Stock Market and that the matter is now closed.

  • Listing deficiency noticeAug 21, 2026

    In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until February 16, 2027, to regain compliance with the Minimum Bid Price Requirement.

  • Business updateJun 18, 2026

    On June 18, 2026, BioCardia, Inc. issued a press release containing its letter to shareholders, which provides an update on the Company's business strategy, top priorities, and business development opportunities.

  • Listing deficiency noticeJun 12, 2026

    on April 10, 2026, BioCardia, Inc. (the "Company," "we," "us" and "our") received a notification letter (the "Notice") from the Nasdaq Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that its amount of stockholders' equity had fallen below the $2,500,000 required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1).

Dividend history and stock splits

BioCardia, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-15May 30, 2024
  • 1-for-9Jun 6, 2019
  • 1-for-12Nov 3, 2017

BCDA short interest

How heavily BCDA is shorted: shares short, days to cover and average daily volume.

Days to cover
1.3
Short interest
619.16K
Avg volume
487.81K

As of · reported to FINRA twice monthly.

BCDA news

The latest news and headlines about BioCardia, Inc. Common Stock (BCDA).

Frequently asked questions

What is the BioCardia, Inc. Common Stock (BCDA) stock price today?

BioCardia, Inc. Common Stock (BCDA) is trading at $0.8906 (-3.30% on the day) as of 2:19:59 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is BioCardia, Inc. Common Stock?

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow.

What is the short interest in BCDA?

As of Sep 30, 2026, BCDA has 619.16K shares short and 1.3 days to cover.

What exchange is BCDA listed on?

BioCardia, Inc. Common Stock (BCDA) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

Build with AI

Build an analysis of BCDA with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BCDA analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.